Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Total 13F shares
-
67,115,861
-
Share change
-
+1,479,891
-
Total reported value
-
$5,854,192,362
-
Put/Call ratio
-
87%
-
Price per share
-
$87.22
-
Number of holders
-
336
-
Value change
-
+$126,899,926
-
Number of buys
-
187
-
Number of sells
-
124
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2024
As of 31 Dec 2024 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 67,115,861 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FMR LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and Avoro Capital Advisors LLC.
This table shows 336 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.